Semaglutide pyridoxine pairs a GLP-1 drug with vitamin B6 to ease nausea. Learn how these compounded formulas work, what the evidence says, and the risks.
Semaglutide pyridoxine is a compounded injectable that pairs semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, with pyridoxine, better known as vitamin B6. Compounding pharmacies add the vitamin in an attempt to reduce the nausea that GLP-1 medications commonly cause. No semaglutide and pyridoxine product is FDA-approved, and compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality.
What Is Semaglutide Pyridoxine?
Semaglutide is a GLP-1 receptor agonist. It mimics a gut hormone that signals fullness to the brain, slows how quickly the stomach empties, and reduces appetite. The FDA approved it for type 2 diabetes and for chronic weight management.
Pyridoxine is a water-soluble B vitamin involved in more than 100 enzyme reactions, including protein metabolism and neurotransmitter production. It is also used as a mild anti-nausea agent, most famously in the FDA-approved doxylamine and pyridoxine combination prescribed for morning sickness.
A semaglutide/pyridoxine blend sold by a compounding pharmacy or telehealth clinic combines both. The semaglutide dose drives the appetite and blood sugar effects. The pyridoxine is a supporting ingredient, not an active weight loss drug.
Why Compounding Pharmacies Add Pyridoxine
The stated rationale is simple: GLP-1 drugs frequently cause nausea, and vitamin B6 has a long history of use for nausea in other settings. Pharmacies reason that adding it may make a compounded injection easier to tolerate.
- Nausea support: B6 is thought to affect serotonin and other signaling pathways involved in the vomiting reflex.
- Product differentiation: In a crowded compounded market, an added vitamin can make one vial look different from another.
- Patient perception: Some people report better tolerance with a B6-containing vial, though this is anecdotal.
Pyridoxine is added to compounded semaglutide in an attempt to reduce nausea, but no large randomized trial has tested the combination directly. The evidence comes from B6 use in pregnancy-related nausea and other conditions, not from GLP-1 users.
The amount of B6 in these vials varies by pharmacy and is often small. Labels may not state the exact concentration, which makes it hard to know what you are actually getting.
Semaglutide Pyridoxine vs. Semaglutide L-Carnitine and Other Additives
Pyridoxine is not the only additive on the market. You may also see semaglutide l carnitine formulas from the same telehealth platforms, and some vials combine B6, B12, and L-carnitine.
| Feature | Semaglutide + Pyridoxine | Semaglutide + L-Carnitine | Semaglutide Alone |
|---|---|---|---|
| Added ingredient | Vitamin B6 | L-carnitine | None |
| Stated purpose | Reduce nausea | Support fat metabolism and energy | Not applicable |
| Evidence for the additive | Limited; drawn from B6 use in other types of nausea | Weak for weight loss in humans | Strong for weight and blood sugar |
| FDA-approved version | No | No | Yes (Ozempic, Wegovy, Rybelsus) |
| Typical form | Weekly injection, sometimes with B12 | Weekly injection | Weekly or daily injection, or daily tablet |
Some formulas go further and put all three together in one vial, marketed as semaglutide pyridoxine l-carnitine. More ingredients do not automatically mean a better result.
If you are comparing options, a resource like semaglutide vs tirzepatide is more useful than comparing filler ingredients, because the active drug is what produces the clinical effect.
Is Compounded Semaglutide With Pyridoxine Still Available?
Compounded semaglutide became popular during the global shortage of brand-name GLP-1 drugs. In 2025, the FDA determined the semaglutide shortage was resolved and set deadlines for compounding pharmacies to stop making copies of the commercially available drug.
Availability now depends on the pharmacy, the state, and the prescriber. Rules differ for 503A pharmacies, which compound for individual patients, and 503B outsourcing facilities, which produce larger batches.
Compounded drugs are not FDA-approved, which means they are not reviewed for safety, effectiveness, or manufacturing quality before they reach a patient.
Side Effects and Safety Considerations
The additive does not change the underlying risk profile of the drug. Most semaglutide side effects come from the GLP-1 itself and are gastrointestinal.
- Nausea, vomiting, diarrhea, and constipation, especially during dose increases
- Abdominal pain, bloating, and reduced appetite
- Gallbladder disease and, rarely, pancreatitis
- Muscle mass loss when weight comes off quickly without enough protein and resistance training
Pyridoxine is generally safe at low doses, but long-term high doses of vitamin B6 can cause peripheral neuropathy, with numbness or tingling in the hands and feet. Because the B6 content of a compounded vial is often unclear, cumulative intake is worth tracking.
Semaglutide is not recommended during pregnancy and is contraindicated in people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. Anyone using a compounded GLP-1 should do so under the supervision of a licensed healthcare professional.
Other Combinations Under Study
Researchers are exploring combinations that target more than one hormone pathway. Studies of cagrilintide and semaglutide, for example, pair an amylin analog with a GLP-1 to see whether the combination outperforms either drug alone. Those programs use precisely manufactured, regulated products, not compounded additives.
Online chatter about stacking retatrutide and semaglutide is not supported by human trial data, and retatrutide is not approved for any use. Mixing investigational drugs with prescription GLP-1s outside a clinical trial carries unknown risks.
What to Discuss With Your Prescriber
Before starting or switching to a compounded product, ask direct questions and get direct answers.
- Which pharmacy makes this vial, and is it licensed in my state?
- How much semaglutide and how much pyridoxine are in each dose?
- What is the plan for nausea if it happens anyway?
- Can I stay on an FDA-approved product instead, and would insurance cover it?
- What monitoring do you recommend for blood sugar, kidney function, and muscle mass?
A vitamin additive is not a substitute for a proper dose titration schedule, a protein-forward diet, and follow-up care. The prescriber, not the label, should decide whether a compounded semaglutide pyridoxine injection is appropriate for you.
Frequently Asked Questions
Is semaglutide with pyridoxine FDA-approved?
No. The FDA has not approved any product that combines semaglutide with pyridoxine. Brand-name semaglutide products such as Ozempic, Wegovy, and Rybelsus are approved, but they contain semaglutide alone. Compounded versions with vitamin B6 are not FDA-approved and are not reviewed for safety, effectiveness, or quality.
Does the vitamin B6 in compounded semaglutide actually reduce nausea?
There is no large randomized trial showing that pyridoxine reduces nausea caused by GLP-1 medications. The rationale comes from studies of B6 for pregnancy-related nausea and other conditions. Some patients report better tolerance with a B6-containing vial, but that is anecdotal and may reflect the dose, the titration pace, or placebo effect.
Is compounded semaglutide with pyridoxine cheaper than Ozempic or Wegovy?
Compounded versions have often been cheaper, especially when insurance does not cover a brand-name GLP-1. However, the FDA determined the semaglutide shortage was resolved in 2025 and set deadlines for compounding pharmacies to stop making copies of the drug, so availability and pricing have changed. Check current pricing, pharmacy licensure, and coverage with your prescriber before deciding.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.